D.J. Girling

Sun Yat-sen University — China

Medicine · Health Sciences

38h-index6.9kcitations117works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(21), Tuberculosis Research and Epidemiology(17), Lung Cancer Diagnosis and Treatment(15), Lung Cancer Treatments and Mutations(15), Neuroendocrine Tumor Research Advances(11)

Publications115 total

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
Journal of Clinical Oncology·2023· 31 citedOpen Access
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Cochrane Database of Systematic Reviews·2015· 362 citedOpen Access
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
The Lancet·2008· 257 citedOpen Access
Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer
PharmacoEconomics·2006· 6 cited
Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial
Journal of Clinical Oncology·2005· 64 cited
Preoperative radiotherapy for esophageal carcinoma
Cochrane Database of Systematic Reviews·2005· 167 citedOpen Access
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer
Lung Cancer·2005· 39 cited
Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up
QJM·2004· 112 cited
O-275 Ifosfamide, carboplatin and etoposide with mid-cycle vincristine (ICE-V) versus standard chemotherapy (C) in patients with small cell lung cancer (SCLC) and good performance status (PS): results of an MRC randomized trial (LU21)
Lung Cancer·2003· 10 cited
O-94 A survey of the peri-operative staging of non-small cell lung cancer (NSCLC) in the UK
Lung Cancer·2003
Conducting trials
2003
Preface
2003
Systematic review and meta-analysis
2003· 4 cited
Putting plans into practice
2003
Title Pages
2003
Benefits of an established trials centre and research group
2003
Analysis
2003
What type of trial is needed?
2003
Design issues for randomized trials
2003· 1 cited
Reporting and interpreting results
2003
page 1 of 6Next →

Frequent Co-authors

Richard Stephens(20), Mahesh Parmar(9), David Machin(8), Penelope Hopwood(7), Lesley Stewart(6), Andrew Nunn(6), Jayne F. Tierney(5), R Sambrook(5), Wallace Fox(5), Peter Fayers(5), D.A. Mitchison(4), B.W. Allen(4), N. M. Bleehen(4), Fergus Macbeth(3), Jean‐Pierre Pignon(3), Matthew Nankivell(3), Nicholas Thatcher(3), J.I.G. Strang(3), K. Nygaard(3), RJ Stephens(3)